Amaryl®М SR: a New Release Form, New Possibilities for The Patients
Journal Title: Міжнародний ендокринологічний журнал - Year 2015, Vol 5, Issue 69
Abstract
The review deals with a new form of oral antidiabetic drugs with a fixed dose — the combination of sustained-release metformin and glimepiride. Amaryl®M SR (2/500 mg) — a new dosage form, which provides a rapid release of glimepiride, and then the slow release of metformin from multipolymer hydrophilic matrix independently of pH. Based on the research of therapeutic efficacy and bioavailability, it is shown that this form is characterized by an optimal pharmacokinetics of metformin and glimepiride, does not increase the incidence of hypoglycemia, may be administered once a day, and is associated with less severe gastrointestinal side effects, as well as has more pronounced compliance. Application of Amaryl®M SR creates new possibilities for patients with type 2 diabetes mellitus in terms of optimizing glycemic control and quality of life.
Authors and Affiliations
V. V. Роltorak, M. Yu. Gorshunska, N. S. Krasova
Keywords
Related Articles
- EP ID EP219667
- DOI -
- Views 77
- Downloads 0
Studying the Efficacy of Vazonat in Comprehensive Treatment of Patients with Diabetes Mellitus Type 2
The objective — to study the effectiveness of Vazonat (meldonium) in patients with diabetes mellitus (DM) type 2 in the comparative 12-week study. Materials and methods. The study involved 55 patients with DM type 2. Pa...
Results of the Dynamic Cohort Study of Parathyroid Gland Function in Patients with Secondary Hyperparathyroidism
In 92 patients with end-stage chronic kidney disease we have evaluated serum levels of parathyroid hormone (PTH), vitamin D3, indicators of phosphorus and calcium metabolism and markers of bone metabolism: at baseline an...
Correction of liver functional state in patients with autoimmune thyroid diseases
The lecture describes the correlation between autoimmune thyroid diseases and liver functional state. The comprehensive method for the treatment of these patients using ursodeoxycholic acid (Ursofalk) is described. Autho...
Apelin Role in the Development of Glucose Metabolism Disorders (Review of the Literature and Our Own Researches)
The physiological and pathogenetic role of adipokine apelin, endogenous ligand of apelin (APJ or APLNR) receptors in the development of glucose metabolism disorders has been analyzed. Established correlations of apelin w...
Changes of lipid metabolism in patients with rheumatoid arthritis and concomitant arterial hypertension, abdominal obesity and diabetes mellitus type 2 depending on the gene polymorphism T-786C of endothelial nitric oxide synthase
We have investigated the violations of blood lipid parameters in patients with rheumatoid arthritis (RA) combined with arterial hypertension (AH), abdominal obesity (AO) and diabetes mellitus type 2 (DM 2) depending on t...